Yize Li Selected Research

Neoplasms (Cancer)

3/2024	Oncogenic KRAS induces arginine auxotrophy and confers a therapeutic vulnerability to SLC7A1 inhibition in non-small cell lung cancer.
2/2024	Pan-cancer proteogenomics characterization of tumor immunity.
1/2024	Low-Dose Chemotherapy Preferentially Shapes the Ileal Microbiome and Augments the Response to Immune Checkpoint Blockade by Activating AIM2 Inflammasome in Ileal Epithelial Cells.
11/2023	Epigenetic regulation during cancer transitions across 11 tumour types.
11/2023	Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin.
2/2023	Nuclear export inhibitor Selinexor targeting XPO1 enhances coronavirus replication.
1/2023	A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma.
1/2023	Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.
1/2023	Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness.
1/2023	Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yize Li Research Topics

Disease

27	Neoplasms (Cancer) 03/2024 - 12/2015
23	Pain (Aches) 04/2024 - 01/2013
21	Hyperalgesia 04/2024 - 01/2013
19	Infections 09/2023 - 07/2012
11	Postoperative Pain 04/2024 - 01/2017
8	Neuralgia (Stump Neuralgia) 04/2024 - 07/2020
8	Virus Diseases (Viral Diseases) 09/2023 - 02/2016
7	Neuroinflammatory Diseases 01/2022 - 01/2020
7	Hypersensitivity (Allergy) 01/2022 - 01/2020
5	COVID-19 05/2022 - 10/2020
5	Tibial Fractures (Fracture, Tibial) 01/2022 - 05/2020
5	Acute Pain 01/2022 - 01/2020
4	Chronic Pain 03/2024 - 01/2022
4	Bone Fractures (Bone Fracture) 01/2022 - 05/2020
4	Inflammation (Inflammations) 01/2022 - 12/2015
3	Coronavirus Infections 01/2021 - 01/2017
3	Cognitive Dysfunction 04/2016 - 03/2014
2	Sleep Deprivation 04/2024 - 01/2022
2	Postoperative Cognitive Complications 04/2024 - 04/2016
2	Peripheral Nervous System Diseases (PNS Diseases) 03/2024 - 12/2023
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2016
2	Squamous Cell Carcinoma of Head and Neck 10/2023 - 01/2021
2	Adenocarcinoma 10/2022 - 01/2022
2	Malaria 01/2022 - 01/2022
2	Cancer Pain 01/2022 - 01/2022
2	Musculoskeletal Pain 01/2022 - 01/2022
2	Carcinogenesis 01/2022 - 01/2021
2	Adenocarcinoma of Lung 11/2021 - 01/2017
2	Zika Virus Infection 01/2021 - 01/2019
1	Fibrosis (Cirrhosis) 05/2024
1	Hypertrophic Cicatrix (Hypertrophic Scar) 05/2024
1	renal Oncocytoma 04/2024
1	Melanoma (Melanoma, Malignant) 01/2024

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2015
14	2-5A-dependent ribonuclease (RNase L)IBA 01/2021 - 08/2013
13	Remifentanil (Ultiva)FDA Link 04/2024 - 01/2013
12	Antiviral Agents (Antivirals)IBA 02/2023 - 08/2013
9	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2017
7	AMPA Receptors (AMPA Receptor)IBA 01/2021 - 01/2018
5	Opioid Analgesics (Opioids)IBA 12/2022 - 01/2013
5	Messenger RNA (mRNA)IBA 01/2022 - 01/2016
5	InterferonsIBA 01/2021 - 08/2013
4	CytokinesIBA 05/2024 - 08/2019
4	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2017
4	Analgesics (Analgesic Drugs)IBA 01/2023 - 05/2021
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2021 - 01/2013
4	Double-Stranded RNA (RNA, Double Stranded)IBA 11/2019 - 01/2016
3	Potassium Channels (Potassium Channel)IBA 04/2024 - 12/2023
3	Paclitaxel (Taxol)FDA LinkGeneric 03/2024 - 01/2022
3	ChromatinIBA 11/2023 - 01/2021
3	Neutralizing AntibodiesIBA 07/2022 - 01/2020
3	ArtesunateIBA 01/2022 - 01/2022
3	1-naphthylacetylspermineIBA 01/2021 - 01/2020
3	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2018
3	2',5'-oligoadenylate (PAPAPA)IBA 11/2020 - 01/2017
3	AcidsIBA 10/2020 - 01/2018
3	Sevoflurane (Ultane)FDA LinkGeneric 04/2016 - 03/2014
2	Histone-Lysine N-MethyltransferaseIBA 04/2024 - 07/2020
2	LigandsIBA 03/2024 - 01/2023
2	EnzymesIBA 03/2024 - 10/2023
2	Aspartic Acid (Aspartate)FDA Link 03/2024 - 01/2022
2	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2023
2	Transcription Factors (Transcription Factor)IBA 11/2023 - 07/2020
2	Histones (Histone)IBA 01/2023 - 10/2022
2	Long Noncoding RNAIBA 10/2022 - 01/2019
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2020
2	Metabotropic Glutamate 5 ReceptorIBA 01/2022 - 01/2022
2	ChemokinesIBA 01/2022 - 01/2022
2	N-methyladenosineIBA 01/2022 - 07/2020
2	MethyltransferasesIBA 01/2022 - 12/2019
2	6-methyladenineIBA 01/2022 - 07/2020
2	Glutamate Receptors (Glutamate Receptor)IBA 01/2022 - 02/2018
2	Caspase 6IBA 01/2021 - 01/2020
2	VaccinesIBA 01/2021 - 01/2018
2	ElementsIBA 01/2021 - 01/2021
2	Purinergic Receptors (Receptors, Purine)IBA 01/2021 - 01/2021
2	Ligases (Synthetase)IBA 11/2020 - 10/2020
2	Protein Kinases (Protein Kinase)IBA 11/2020 - 01/2018
2	naltrindoleIBA 02/2018 - 01/2015
1	Interleukin-6 (Interleukin 6)IBA 05/2024
1	InterleukinsIBA 05/2024
1	SodiumIBA 04/2024
1	PotassiumIBA 04/2024
1	EuchromatinIBA 04/2024
1	Protein SIBA 03/2024
1	7,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA 03/2024
1	Arginine (L-Arginine)FDA Link 03/2024
1	Urea (Carbamide)FDA LinkGeneric 03/2024
1	pyrimidineIBA 03/2024
1	CitrullineIBA 03/2024
1	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 03/2024
1	InflammasomesIBA 01/2024
1	Streptozocin (Streptozotocin)FDA Link 12/2023
1	TransposasesIBA 11/2023

Therapy/Procedure

12	Therapeutics 10/2023 - 01/2018
6	Orthopedic Procedures 01/2022 - 03/2014
2	Immunotherapy 02/2024 - 01/2024
2	Drug Therapy (Chemotherapy) 01/2024 - 12/2023
2	Spinal Injections 01/2022 - 05/2020
1	Perioperative Period 04/2024